Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
  1. 4 Grant or award Director acquired 644 shares (grant or award)
  2. 4 Grant or award Director acquired 534 shares (grant or award)
  3. 4 Grant or award Director acquired 534 shares (grant or award)
  4. 4 Grant or award Director acquired 1,024 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market sale Director sold 14,715 shares at an average $150.51 ($2,214,819)
  7. 4 Shares withheld for taxes Senior VP, R&D gave up 712 shares (to pay taxes)
  8. 4 Shares withheld for taxes Gebski Christine gave up 335 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Financial Officer gave up 712 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Operating Officer gave up 335 shares (to pay taxes)
  11. 4 Exercise or conversion Chief Financial Officer acquired 4,166 shares (option exercise)
  12. 4 Shares withheld for taxes Chief Executive Officer gave up 7,292 shares (to pay taxes)
  13. 4 Open-market sale Director sold 2,000 shares at an average $198.03 ($396,060)
  14. 4 Shares withheld for taxes Senior VP, R&D gave up 2,534 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Financial Officer gave up 3,824 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Executive Officer gave up 19,292 shares (to pay taxes)
  17. 4 Shares withheld for taxes Gebski Christine gave up 1,060 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Executive Officer gave up 1,170 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 269 shares (to pay taxes)
  20. 4 Shares withheld for taxes Senior VP, R&D gave up 188 shares (to pay taxes)

Page 10 of 34 · 669 filings